Sulfacetamide Sodium

磺胺醋酰钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfacetamide Sodium
Drug Alias Name磺醋酰胺Sulfacetamida乙酰磺胺Sulfacetamidum磺乙酰胺 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsAcne VulgarisBlepharitisConjunctivitis +[4] 
Global Approved IndicationsAcne VulgarisBlepharitisConjunctivitis +[4] 
Approved Indications in ChinaBlepharitisConjunctivitisTrachoma
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/23
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb (Singapore) Pvi LtdJiangsu Shenhua Pharmaceutical Co Ltd
Inactive CompaniesSandoz Canada IncorporatedSchering-Plough Canada Inc
Active IndicationsAcne VulgarisBlepharitisConjunctivitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeD10AF06S01AB04
Related LinksWikipediaDrugBankKEGG